In the version of this article originally published, the western blot image for VINC in Fig. 3g was a duplicate of that for LSD1. The error has been corrected in the HTML and PDF versions of the paper.
. Author manuscript; available in PMC: 2021 May 10.
Published in final edited form as: Nat Cell Biol. 2020 Jun;22(6):752. doi: 10.1038/s41556-020-0533-9
Author Correction: Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis
Donglim Esther Park
1,2, Jingwei Cheng
2,3, John P McGrath
4, Matthew Y Lim
1,5, Camille Cushman
1,2, Selene K Swanson
6, Michelle L Tillgren
7, Joao A Paulo
5, Prafulla C Gokhale
7, Laurence Florens
6, Michael P Washburn
6,8, Patrick Trojer
4, James A DeCaprio
9,10,11
Donglim Esther Park
1Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Find articles by Donglim Esther Park
Jingwei Cheng
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
3Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Find articles by Jingwei Cheng
Matthew Y Lim
1Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA
5Department of Cell Biology, Harvard Medical School, Boston, MA, USA
Find articles by Matthew Y Lim
Camille Cushman
1Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Find articles by Camille Cushman
Selene K Swanson
6Stowers Institute for Medical Research, Kansas City, MO, USA
Find articles by Selene K Swanson
Michelle L Tillgren
7Experimental Therapeutics Core, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA
Find articles by Michelle L Tillgren
Joao A Paulo
5Department of Cell Biology, Harvard Medical School, Boston, MA, USA
Find articles by Joao A Paulo
Prafulla C Gokhale
7Experimental Therapeutics Core, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA
Find articles by Prafulla C Gokhale
Laurence Florens
6Stowers Institute for Medical Research, Kansas City, MO, USA
Find articles by Laurence Florens
Michael P Washburn
6Stowers Institute for Medical Research, Kansas City, MO, USA
8Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA
Find articles by Michael P Washburn
James A DeCaprio
9Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
11Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Find articles by James A DeCaprio
1Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
3Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
4Constellation Pharmaceuticals, Cambridge, MA, USA
5Department of Cell Biology, Harvard Medical School, Boston, MA, USA
6Stowers Institute for Medical Research, Kansas City, MO, USA
7Experimental Therapeutics Core, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA
8Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA
9Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
11Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
✉
Corresponding author: james_decaprio@dfci.harvard.edu.
PMCID: PMC8107828 NIHMSID: NIHMS1595961 PMID: 32415271
The publisher's version of this article is available at Nat Cell Biol
This corrects the article "Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis" on page 603.